MED13L (mediator complex subunit 13L)

2007-04-01  

Identity

HGNC
LOCATION
12q24.21
LOCUSID
ALIAS
MRFACD,PROSIT240,THRAP2,TRAP240L
FUSION GENES

Other Information

Locus ID:

NCBI: 23389
MIM: 608771
HGNC: 22962
Ensembl: ENSG00000123066

Variants:

dbSNP: 23389
ClinVar: 23389
TCGA: ENSG00000123066
COSMIC: MED13L

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000123066ENST00000281928Q71F56
ENSG00000123066ENST00000548743F8VRB8
ENSG00000123066ENST00000549786H0YHC1
ENSG00000123066ENST00000551197A0A3B3IS36
ENSG00000123066ENST00000647567A0A3B3IS48
ENSG00000123066ENST00000649607A0A3B3IS46
ENSG00000123066ENST00000649775A0A3B3IRS4
ENSG00000123066ENST00000650226A0A3B3IRX3

Expression (GTEx)

0
5
10
15
20
25
30
35
40

Pathways

PathwaySourceExternal ID
Thyroid hormone signaling pathwayKEGGhsa04919
MetabolismREACTOMER-HSA-1430728
Metabolism of lipids and lipoproteinsREACTOMER-HSA-556833
Fatty acid, triacylglycerol, and ketone body metabolismREACTOMER-HSA-535734
Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)REACTOMER-HSA-400206
PPARA activates gene expressionREACTOMER-HSA-1989781
Developmental BiologyREACTOMER-HSA-1266738
Transcriptional regulation of white adipocyte differentiationREACTOMER-HSA-381340

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
375120362023Molecular and Functional Characterisation of a Novel Intragenic 12q24.21 Deletion Resulting in MED13L Haploinsufficiency Syndrome.0
375120362023Molecular and Functional Characterisation of a Novel Intragenic 12q24.21 Deletion Resulting in MED13L Haploinsufficiency Syndrome.0
328021982020MED13L integrates Mediator-regulated epigenetic control into lung cancer radiosensitivity.12
328021982020MED13L integrates Mediator-regulated epigenetic control into lung cancer radiosensitivity.12
291599872018MED13L loss-of-function variants in two patients with syndromic Pierre Robin sequence.2
295119992018MED13L-related intellectual disability: involvement of missense variants and delineation of the phenotype.13
291599872018MED13L loss-of-function variants in two patients with syndromic Pierre Robin sequence.2
295119992018MED13L-related intellectual disability: involvement of missense variants and delineation of the phenotype.13
283712822017MED13L haploinsufficiency syndrome: A de novo frameshift and recurrent intragenic deletions due to parental mosaicism.10
286457992017Genotype-phenotype evaluation of MED13L defects in the light of a novel truncating and a recurrent missense mutation.23
283712822017MED13L haploinsufficiency syndrome: A de novo frameshift and recurrent intragenic deletions due to parental mosaicism.10
286457992017Genotype-phenotype evaluation of MED13L defects in the light of a novel truncating and a recurrent missense mutation.23
275005362016De novo mutations in genes of mediator complex causing syndromic intellectual disability: mediatorpathy or transcriptomopathy?18
275005362016De novo mutations in genes of mediator complex causing syndromic intellectual disability: mediatorpathy or transcriptomopathy?18
252491832015Genome-wide association study in Chinese identifies novel loci for blood pressure and hypertension.100

Citation

Dessen P

MED13L (mediator complex subunit 13L)

Atlas Genet Cytogenet Oncol Haematol. 2007-04-01

Online version: http://atlasgeneticsoncology.org/gene/47174/haematological-explorer/css/template-nav.css